Paclitaxel, Carboplatin, and Cetuximab Followed by Chemoradiotherapy in Patients With Unresectable Locally Advanced HNSCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cancer Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Multicenter Phase II Trial of Paclitaxel, Carboplatin, and Cetuximab Followed by Chemoradiotherapy in Patients With Unresectable Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Cancer Med 2020 Jan 13;[EPub Ahead of Print], T Enokida, T Ogawa, A Homma, K Okami, S Minami, A Nakanome, Y Shimizu, D Maki, Y Ueda, T Fujisawa, A Motegi, A Ohkoshi, J Taguchi, K Ebisumoto, S Nomura, S Okano, M TaharaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.